Terns Pharmaceuticals
TERN
TERN
128 hedge funds and large institutions have $310M invested in Terns Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.02% less ownership
Funds ownership: 95.18% → 95.16% (-0.02%)
7% less funds holding
Funds holding: 137 → 128 (-9)
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
Holders
128
Holding in Top 10
3
Calls
$910K
Puts
$399K
Top Buyers
| 1 | +$7.16M | |
| 2 | +$4.77M | |
| 3 | +$4.76M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$890K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$799K |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$2.11M | |
| 3 | -$1.91M | |
| 4 |
Barclays
London,
United Kingdom
|
-$1.52M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.34M |
